Immuneering Corp. Class AIMRX
13F holders, Q3 2024 (September 30)38holders −21
6new positions
27sold out
1famous investor
$2.50avg. 13F price*
At the end of Q3 2024, 38 institutions reported holding Immuneering Corp. Class A (IMRX) in their 13F filings, down 21 from Q2 2024. 6 opened new positions and 27 sold out. The largest holders were Vanguard Group Inc. ($2.7M), T. Rowe Price Associates Inc. ($2.0M) and Morgan Stanley ($1.1M). One famous investor held it Israel Englander (0.0% of Millennium Management's portfolio).
- Company
- Immuneering Corp. Class A
- CUSIP
- 45254E107
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q2 2024 → Q3 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 6 | $266K |
| Exits | 27 | $5.3M |
All 13F filers, Q2 2024 → Q3 2024: 614,429 shares bought and 5,638,519 shares sold, net −5,024,090 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 38 holders
| Vanguard Group Inc. | 0.00% | No change | 1,070,322 | $2.7M |
| T. Rowe Price Associates Inc. | 0.00% | Reduce -5.7% | 810,127 | $2.0M |
| Morgan Stanley | 0.00% | Add +875.7% | 449,311 | $1.1M |
| BlackRock, Inc. | 0.00% | — | 318,419 | $793K |
| Millennium Management | 0.00% | Reduce -74.2% | 246,270 | $613K |
| Geode Capital Management, LLC | 0.00% | Reduce -5.5% | 209,641 | $522K |
| Southport Management, L.L.C. | 1.90% | Add +28.0% | 205,000 | $510K |
| Prosight Management, LP | 0.12% | Reduce -65.5% | 190,000 | $473K |
| TD Asset Management Inc | 0.00% | No change | 150,876 | $401K |
| Manufacturers Life Insurance Company, The | 0.00% | No change | 82,638 | $206K |
| State Street Corp. | 0.00% | No change | 69,235 | $172K |
| Corient Private Wealth LP | 0.00% | Add +47.0% | 63,740 | $159K |
| Exchange Traded Concepts, LLC | 0.00% | Reduce -22.1% | 58,349 | $145K |
| HighTower Advisors, LLC | 0.00% | Add +21.4% | 53,360 | $132K |
| Tidemark, LLC | 0.05% | New | 51,850 | $129K |
| Two Sigma Investments, LP | 0.00% | Reduce -80.8% | 40,431 | $101K |
| Northern Trust Corp. | 0.00% | Reduce -75.0% | 39,729 | $99K |
| UBS Group AG | 0.00% | Add +347.3% | 31,545 | $79K |
| Bank of America Corp. | 0.00% | Reduce -2.3% | 31,387 | $78K |
| Bridgeway Capital Management, LLC | 0.00% | Reduce -46.3% | 28,949 | $72K |
| PNC Financial Services Group, Inc. | 0.00% | Reduce -0.5% | 20,000 | $50K |
| Point72 Asia (Singapore) Pte. Ltd. | 0.01% | Reduce -48.5% | 17,824 | $44K |
| Qube Research & Technologies Ltd | 0.00% | Add +37.1% | 14,823 | $37K |
| Man Group plc | 0.00% | New | 13,778 | $34K |
| Dimensional Fund Advisors LP | 0.00% | No change | 13,366 | $33K |
| XTX Topco Ltd | 0.00% | Reduce -65.5% | 11,779 | $29K |
| Royal Bank of Canada | 0.00% | New | 11,294 | $28K |
| Vontobel Holding Ltd. | 0.00% | New | 10,000 | $25K |
| Corsair Capital Management, L.P. | 0.01% | New | 10,000 | $25K |
| CIBC Private Wealth Group LLC | 0.00% | New | 10,000 | $25K |
| Barclays PLC | 0.00% | Reduce -2.5% | 9,924 | $25K |
| Federated Hermes, Inc. | 0.00% | Add +13.9% | 5,135 | $13K |
| JPMorgan Chase & Co. | 0.00% | Add +22.8% | 2,424 | $6K |
| Tower Research Capital LLC (TRC) | 0.00% | Reduce -83.7% | 1,968 | $5K |
| Citigroup Inc. | 0.00% | Reduce -83.0% | 796 | $2K |
| Cubist Systematic Strategies, LLC | 0.00% | Reduce -88.7% | 660 | $2K |
| EverSource Wealth Advisors, LLC | 0.00% | No change | 345 | $859 |
| Point72 (DIFC) Ltd | 0.00% | Reduce -99.7% | 16 | $40 |
"% of holder's portfolio" is IMRX's weight in each manager's 13F, not the share of Immuneering Corp. Class A the manager owns.